FDA Approves Severe Thermal Burn Skin Therapy Device
September 22nd 2018Patients treated with the RECELL Systems were required to donate 97.5% less skin than standard-of-care, and reported statistically significant reduction in patient-reported pain, increases in satisfaction, and improved outcomes in donor scars.
Read More
FDA: No Evidence Linking Pimavanserin to Parkinson Patient Deaths
September 20th 2018The FDA’s post-marketing review concludes a five-month speculation which began when CNN reported the Acadia Pharmaceutical antipsychotic therapy was associated with more than 700 deaths of patients with Parkinson disease since June 2016.
Read More
Secukinumab Reports Real-World Benefits, Tolerability in PROSPECT Trial
September 13th 2018Novartis reported that 59% of patients at 24 weeks experienced little to no impact of their condition on their quality of life. Additionally, 87% of bio-naïve psoriasis patients remained on secukinumab through 12 months, indicating its tolerability in real-world settings.
Read More
FDA Accepts Aflibercept Application for Diabetic Retinopathy
September 13th 2018The acceptance comes less than a month since the FDA had approved the anti-VEGF therapy for the treatment of wet AMD. Its mechanism of action allows it to block new blood vessel growth and the passing of fluids through blood vessels in the eye.
Read More
FDA Approves New Dosage Strength for Buprenorphine and Naloxone Film Therapy
September 8th 2018The sublingual film therapy has been approved under a 16 mg/ 4 mg dosage strength for the maintenance treatment of opioid dependence, adding to therapy options which include both brand name and generic versions.
Read More
Single-Dose Baloxavir Marboxil Improves Influenza Recovery Rates, Safety
September 7th 2018With another randomized, controlled trial involving patients at high risk for flu complications currently underway, investigators found that baloxavir may provide an option for patients with uncomplicated influenza.
Read More
CDC Creates New Guidelines for Addressing Mild TBI, Concussions in Children
September 4th 2018More than 2 million US outpatient visits and 3 million emergency department visits from 2005-2009 were accounted to children seeking care for mild TBI. Until now, no evidence-based clinical guidelines for pediatric mild TBI existed.
Read More
Deepak L. Bhatt, MD, MPH on the New NDEP Diabetes Guiding Principles
September 3rd 2018The principles included new and updated evidence over recent years in the field of diabetes self-management, education, and support, as well as shared decision-making skills and individualized care for patients.
Read More
Older, Minority Patients More Likely to Miss Anti-VEGF Treatment for nAMD
August 31st 2018Among patients who were lost to follow-up over a year, just 7.4% attended a follow-up visit after the observed 12 months. In the total loss to follow-up patient population, they reported a mean 7.8 injection treatments and 8.5 clinic visits. In patients not lost, they reported a mean 14.3 injections and 17.1 visits.
Read More